UK’s NICE Goes Ahead With Parkinson’s Product Funding But Pending Real-World Data
Five remote monitoring medical devices that have “transformational” potential for Parkinson’s disease are to be conditionally funded via the UK’s National Health Service in a drive to address clinical and cost-effectiveness uncertainties using data from real patients.
You may also be interested in...
Yet another EU regulatory organization has stressed the need for action to address MDR capacity problems. According to CAMD, underlying factors and causes of the crisis must be identified.
There are growing fears that the new EU medtech regulations could result in products used for children or rare diseases vanishing from the market. In an interview with Medtech Insight, regulatory expert Tom Melvin explains how these devices can be protected.
The health sector has experienced an increase in cybersecurity incidents since the COVID-19 pandemic. While health systems are becoming more prepared for attacks and breaches, the sector remains vulnerable, EU cyber agency ENISA warns.